IBD logo

Inspire Corporate Bond Impact ETF (IBD)

$24.17

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on IBD

AUM

$454396000

P/E ratio

29.9

Dividend yield

3.8671%

Expense ratio

0.43%

Beta

0.205334

Price on IBD

Previous close

$24.18

Today's open

$24.12

Day's range

$24.08 - $24.18

52 week range

$22.84 - $24.85

Profile about IBD

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

IBD industries and sectors

Bonds

Domestic

News on IBD

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.

news source

Zacks Investment Research • Dec 3, 2025

news preview

What's Going On With Treasury Rates?

We think the Fed has time to assess the impact of tariffs, and we expect it to wait to cut rates until the data show that tariffs are impacting the real economy. So far, there are no signs of recession in the hard data. The tariff pause offers the possibility to avoid worst-case economic scenarios before the damage is crystalized. We believe technical factors will continue to drive market dislocations in spreads and sectors, and that active managers can navigate this more effectively.

news source

Seeking Alpha • Apr 18, 2025

news preview

Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases

LA JOLLA, Calif.--(BUSINESS WIRE)--As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting quality of life and placing an unprecedented financial and care burden on overwhelmed families, government agencies and healthcare providers. To help address this growing challenge, scientists at Scripps Research and its nonprofit drug development arm, the Calibr-Skaggs Institute for Innovative Medicines, are advancing novel regenerative.

news source

Business Wire • Oct 30, 2024

news preview

Funds Keep Loading Up On Nvidia, Meta And Three Other Magnificent Seven Stocks

Nvidia stock is one of 15 stocks funds are buying even as markets come under pressure. Other stocks include Meta, Google, Amazon and Microsoft.

news source

Investors Business Daily • Apr 17, 2024

news preview

The Credit Opportunity In M&A

M&A was almost dormant in 2023. In the US, as a proportion of the market value of the benchmark equity indices, it fell to its lowest level in 20 years, according to McKinsey. Credit investors are not traditionally supposed to be fans of M&A, and it's true we are wary of leveraging M&A, where debt is loaded onto balance sheets to buy competitors. We are seeing a comeback for M&A that we think is likely to continue through 2024.

news source

Seeking Alpha • Mar 4, 2024

news preview

11 Stocks Are Primed To Blow Away Earnings Expectations

Want to put an S&P 500 investor in a good mood during earnings season? A huge earnings surprise would do it.

news source

Investors Business Daily • Oct 14, 2022

news preview

Is Inspire Corporate Bond ESG ETF (IBD) a Strong ETF Right Now?

Smart Beta ETF report for IBD

news source

Zacks Investment Research • Jul 13, 2022

news preview

Inspire ETFs Reports Expense Ratio Reductions for 7 Funds

Inspire Investing has announced fee reductions on seven of its biblically responsible, faith-based ESG ETFs BOISE, Idaho , May 2, 2022 /PRNewswire/ -- Inspire Investing, the world's largest provider of biblically responsible ESG ETFs, reported fee reductions on seven of its eight exchange traded funds. This reduction in fees is due mostly to the rapid growth that Inspire has achieved and covers a broad range of investment solutions, from global and U.S. equity to fixed income, momentum, and tactical strategies.

news source

PRNewsWire • May 2, 2022

news preview

ETF Odds & Ends: Regents Park Adds Hedged Fund

It was a busy week, especially for expense ratio changes.

news source

ETFcom • Apr 1, 2022

news preview

Is Inspire Corporate Bond Impact ETF (IBD) a Strong ETF Right Now?

Smart Beta ETF report for IBD

news source

Zacks Investment Research • Mar 10, 2022

news preview

¹ Disclosures

Get started with M1

Invest in Inspire Corporate Bond Impact ETF

Open an M1 investment account to buy and sell Inspire Corporate Bond Impact ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in IBD on M1